Showing results (91-100 of 146) with videos related to

Sort By:
Pageof 15
Journal of Pharmacokinetics and Pharmacodynamics|June 4, 2026
Exposure-safety analyses of talazoparib in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) in the TALAPRO-2 trialYibo Wang, Mark Hadigol, Victor Ruberio Lincha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2010
Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cellsYanyan Li, Tao Zhang, Hasan Korkaya, et al.
Cancer Research|May 20, 2016
Sustained Accumulation of Microtubule-Binding Chemotherapy Drugs in the Peripheral Nervous System: Correlations with Time Course and Neurotoxic SeverityKrystyna M Wozniak, James J Vornov, Ying Wu, et al.
Targeted Oncology|August 20, 2025
Elranatamab Fixed Dosing: A Safe, Effective, and Convenient Dosing ApproachMohamed Elmeliegy, Pooneh Soltantabar, Jennifer Hibma, et al.
Ophthalmic Plastic and Reconstructive Surgery|November 16, 2023
Optimizing Ophthalmology Patient Education via ChatBot-Generated Materials: Readability Analysis of AI-Generated Patient Education Materials and The American Society of Ophthalmic Plastic and Reconstructive Surgery Patient BrochuresKevin Eid, Alen Eid, Diane Wang, et al.
Oncology and Therapy|March 2, 2026
Summary of Research: Elranatamab Fixed Dosing-A Safe, Effective, and Convenient Dosing ApproachMohamed Elmeliegy, Pooneh Soltantabar, Jennifer Hibma, et al.
Documenta Ophthalmologica. Advances in Ophthalmology|June 17, 2020
Oscillatory potentials in patients with birdshot chorioretinopathyDiane Wang, Archana Nair, Naomi Goldberg, et al.
Respiratory Physiology & Neurobiology|March 2, 2010
Variation of lipopolysaccharide-induced acute lung injury in eight strains of miceAnn-Sophie Alm, Ka Li, Hong Chen, et al.
Clinical Pharmacokinetics|March 9, 2021
The Effect of Renal Impairment on the Pharmacokinetics and Safety of Talazoparib in Patients with Advanced Solid TumorsChandrasekar Durairaj, Jayeta Chakrabarti, Cristiano Ferrario, et al.
Plos One|June 14, 2014
Development and evaluation of small peptidomimetic ligands to protease-activated receptor-2 (PAR2) through the use of lipid tetheringScott Boitano, Justin Hoffman, Dipti V Tillu, et al.
Pageof 15